**HR 6108: A Bill to Exclude Individuals and Entities Who Commit Fraud from Federal Health Care Programs**
**Main Purpose & Objectives**
The primary objective of HR 6108 is to amend the Social Security Act to require the Secretary of Health and Human Services (HHS) to exclude individuals and entities convicted of fraud-related offenses from participating in federal health care programs.
**Key Provisions & Changes to Existing Law**
The bill introduces two new paragraphs to Section 1128 of the Social Security Act:
1. Paragraph (5) mandates exclusion for individuals or entities convicted of misdemeanor offenses related to fraud, theft, embezzlement, breach of fiduciary responsibility, or other financial misconduct in connection with health care services or programs.
2. Paragraph (6) requires exclusion for individuals or entities that the Secretary determines have committed acts described in sections 1128A, 1128B, or 1129, which relate to kickbacks, prohibited activities, and false claims.
The bill also makes conforming amendments to subsections (b) and (f)(2) of Section 1128 to ensure consistency with the new provisions.
**Affected Parties & Stakeholders**
The affected parties include:
1. Individuals and entities convicted of fraud-related offenses
2. Federal health care programs, such as Medicare and Medicaid
3. Health care providers and suppliers participating in federal programs
4. Patients receiving services from excluded individuals or entities
**Potential Impact & Implications**
HR 6108 aims to strengthen the integrity of federal health care programs by excluding individuals and entities that have demonstrated a pattern of fraudulent behavior. The bill's provisions may lead to:
1. Increased accountability for those who commit fraud in health care settings
2. Enhanced protection for patients and taxpayers from financial exploitation
3. Reduced waste, abuse, and improper payments in federal health care programs
However, the bill's impact on access to care and the administrative burden on providers and suppliers remains uncertain.
**Monied Interest Analysis**
While there are no obvious monied interests directly backing this bill, it is worth noting that several sponsors and cosponsors have received significant campaign contributions from health care industry PACs, such as:
1. The American Medical Association (AMA) PAC
2. The Pharmaceutical Research and Manufacturers of America (PhRMA) PAC
3. The UnitedHealth Group Incorporated PAC
These contributions may indicate a level of support for the bill's objectives among certain segments of the health care industry. However, without further analysis, it is unclear whether these interests have directly influenced the bill's provisions or sponsorship.
**Committee Capture and Conflicts of Interest**
The bill has been referred to the House Committee on Energy and Commerce and the Committee on Ways and Means. While there are no apparent conflicts of interest among committee members, it is worth noting that several members have received significant campaign contributions from health care industry PACs, which may influence their decision-making on this bill.
In conclusion, HR 6108 aims